US 9206159
Piperazine-piperidine compounds as hepatitis C virus inhibitors
granted A61KA61K31/496A61K31/506
Quick answer
US patent 9206159 (Piperazine-piperidine compounds as hepatitis C virus inhibitors) held by Theravance Biopharma R&D IP, LLC expires Mon Dec 03 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Theravance Biopharma R&D IP, LLC
- Grant date
- Tue Dec 08 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Dec 03 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 21
- CPC classes
- A61K, A61K31/496, A61K31/506, A61K31/55, A61K45/06